Ophthalmic drops

  • Biotear

    Biotear®

    Polyvinyl Alcohol: Biotear is used topically to provide tear-like lubrication for the symptomatic relief of dry eyes and eye irritation associated with deficient tear production

  • Brimonidin

    Brimonidine®

    Brimonidine is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

  • Co biosopt

    Co-Biosopt®

    Dorzolamide / Timolol: Co-Biosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.

  • Ketobiofen

    Ketobiofen®

    Ketotifen fumarate: Ketobiofen is indicated for the temporary prevention of itching of the eye due to allergic conjunctivitis.

  • Xalabiost

    Xalabiost®

    Latanoprost: Xalabiost is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

  • Biosopt

    Biosopt®

    Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma

  • Biocarpin

    Biocarpine®

    Pilocarpine: Treatment of chronic simple glaucoma, chronic angle-closure glaucoma, acute angle-closure glaucoma, pre- and postoperative management of intraocular tension, treatment of mydriasis.

  • Timobiol

    Timobiol®

    Timolol maleate: Treatment of elevated IOP in chronic open-angle glaucoma, ocular hypertension, aphakic glaucoma patients, some patients with secondary glaucoma, and in patients with elevated IOP who need ocular pressure lowering.

  • Biofenac

    Biofenac®

    Diclofenac Sodium: Biofenac is indicated for the treatment of post operative inflammation in patient who have undergone cataract extraction and for the temporary relief of pain and photophobia in patiens undergoing corneal refractive surgery. It is also indicated in the treatment of conjunctivitis, keratoconjunctivitis, corneal ulcer and post traumatic inflammation of the cornea and conjunctiva, provided that these conditions are not associated with an ocular infection.Biofenac is also indicated to inhibit intraoperative miosis, which may occur in response to surgical trauma despite preoperative establishment of mydriasis.

Copyright © 2017 Bakhtar Bioshimi Co, All rights reserved.